Antimicrobial resistance is dramatically increasing worldwide and is becoming one of the most urgent public health threats. There is an urgent need for actions to reverse the curve of antimicrobial resistance dissemination and to […]
INCEPTION – Institut Convergence for the study of Emergence of Pathology Through Individuals and Populations
IINCEPTION Goal The Inception’s goal is to develop a core structure to mobilize data resources, numerical sciences, and fundamental experimental biology in a range of health issues (Official website here : https://www.inception-program.fr/en). Inception program […]
LabEx IBEID – Integrative Biology of Emerging Infectious Diseases
Presentation The aim of the Integrative Biology of Emerging Infectious Diseases (IBEID) project, coordinated by Professors Philippe Sansonetti and Pascale Cossart, is to develop a structure to anticipate and tackle emerging infectious diseases (EIDs). […]
Whole genome sequencing and artificial intelligence to characterise and diagnose antibiotic resistance and capacity to escape treatment: Seq2Diag
Project in collaborations with the following partners; – InBio Unit, Inria (Grégory Batt) -CNRS, Laboratoire de Recherche en Informatique, Université Paris-Saclay (Flora Jay) -INSERM, Délégation régionale Paris 11, U1184 RESIST Team (Thierry Naas) -CNRS, […]
High-throughput identification of antibiotic resistance progenitors across interconnected settings: PRE-EMPT
Project with the following partners: -INSERM UMR1092, Université de Limoges (Marie-Cécile Ploy) -Anses, Unité Antibiorésistance et virulence bactériennes (Jean-Yves Madec) -INRAE, UMR-1282, Université de Tours (Sébastien Leclercq)
Dynamics of Gut Microbiota
Acquisition of antibiotic resistant bacteria and development of the gut microbiome in neonates in low-income countries. Antibiotic resistance represents a major health issue worldwide. The situation is particularly acute in low-income countries (LIC), due […]
2022Specificities and Commonalities of Carbapenemase-Producing Escherichia coli Isolated in France from 2012 to 2015., mSystems 2022 Jan; (): e0116921.
2021The CovR regulatory network drives the evolution of Group B Streptococcus virulence., PLoS Genet 2021 Sep; 17(9): e1009761.
2021A model-based approach to characterize enzyme-mediated response to antibiotic treatments: going beyond the SIR classification, bioRxiv. 2021.07.16.452741.
2021Evolution of VIM-1-Producing Klebsiella pneumoniae Isolates from a Hospital Outbreak Reveals the Genetic Bases of the Loss of the Urease-Positive Identification Character., mSystems 2021 Jun; (): e0024421.
2020Diversity of mucoid to non-mucoid switch among carbapenemase-producing Klebsiella pneumoniae., BMC Microbiol 2020 Oct; 20(1): 325.
2020Concomitant carriage of KPC-producing and non-KPC-producing Klebsiella pneumoniae ST512 within a single patient., J Antimicrob Chemother 2020 Aug; 75(8): 2087-2092.
2020A single Proteus mirabilis lineage from human and animal sources: a hidden reservoir of OXA-23 or OXA-58 carbapenemases in Enterobacterales., Sci Rep 2020 06; 10(1): 9160.
2020Emergence of New Non-Clonal Group 258 High-Risk Clones among Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Isolates, France., Emerg Infect Dis 2020 06; 26(6): 1212-1220.
2020Antibiotic resistance: turning evolutionary principles into clinical reality., FEMS Microbiol Rev 2020 03; 44(2): 171-188.
2020Stepwise evolution and convergent recombination underlie the global dissemination of carbapenemase-producing Escherichia coli., Genome Med 2020 01; 12(1): 10.
+View full list of publications